Traded as | NASDAQ: MBLX |
---|---|
Industry | Bioplastics, Specialty Chemicals |
Headquarters | Cambridge, MA, USA |
Key people
|
Joseph Shaulson (CEO), Anthony J. Sinskey (Founder), Joseph D. Hill (CFO), Oliver P. Peoples (CSO) |
Owner | Fidelity Investments, Jack Schuler, State Farm Insurance, others |
Number of employees
|
95 |
Website | www |
Metabolix, Inc. is a bioplastics technology development and commercialization company founded in 1992. Metabolix is an advanced biomaterials company focused on sustainable solutions for the plastics and chemicals industries. The company’s headquarters is located in Cambridge, Massachusetts.
Since 2006 Metabolix has been a publicly traded company. As of December 2013, Metabolix has approximately 100 full-time employees and offices in the US, Canada, and Germany.
Metabolix develops and commercializes high-performance PHA biopolymers targeted to the markets for film and bag applications, performance additives and functional biodegradation. The company opened an office in Cologne, Germany in April 2012.
Founded in 1992 with the help of a licensing agreement with Massachusetts Institute of Technology (MIT), Metabolix, Inc. is a bioscience company with headquarters in Cambridge, Massachusetts. Metabolix provides sustainable solutions to the plastic, chemical and energy industries. Oliver Peoples, Ph.D., and Anthony Sinskey, Ph.D., co-founded Metabolix after work at the (MIT) that identified the elementary methods and means for engineering polyhydroxyalkanoates out of plants and bacteria, thus making them biodegradable.
In April, 2012, Metabolix opened its first international office in Cologne, Germany. The office is strategically located in the BioCampus Cologne life science park, which has been one of Germany’s largest biotechnology parks since 2002. This office was opened to handle business development, customer service, and technical support to Metabolix’s European business partners and biopolymer customers.
Metabolix, Inc. is developing and commercializing high-performance PHA biopolymers for performance additives, film and bag applications, and functional biodegradation. Metabolix’s technology platforms are creating sustainable solutions in the world of plastics, chemicals and energy. The company is also in the process of developing platforms to co-produce plastics, chemicals, and energy from crops
Metabolix has been recognized for its research, development and product innovations through a series of prestigious awards and grants including: the “Presidential Green Chemistry Challenge Award” (2005), the "New Technologies in Renewable Materials and Processes Award” (2006), the “Technology Pioneer Award” (2010), and the Museum of Science Boston’s “Invented Here!” award (2011).